Document is current
Any future updates will be listed below
-
Authors
Hossain, Mohammad Shahadat
Rasiah, Pratheepa Kumari
Seetharaman, Amritha T. M.
Alvarado, Dulce
Luo, Megan
Wohlschlegel, James A.
Pentecost, Mickey
Gangaraju, Rajashekhar https://orcid.org/0000-0002-6664-8286
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R56NS127924, R56NS127924, R56NS127924)
Congressionally Directed Medical Research Programs (W81XWH-22-1-0697, W81XWH-22-1-0697, W81XWH-22-1-0697, W81XWH-22-1-0697)
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 30 April 2025
First Online: 29 May 2025
Declarations
:
: MP is a co-founder and holds equity in Diadem Biotherapeutics Inc., whose interest is in developing sEV-engineered products for anti-inflammatory diseases. DA is an employee of Diadem Biotherapeutics Inc. None of the other authors declare any financial conflicts.
